Klu Interna & Farmakologi
-
Upload
princessisma -
Category
Documents
-
view
256 -
download
0
description
Transcript of Klu Interna & Farmakologi
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 1/161
UKDI
2015
PRAJOGO WIBOWO
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 2/161
Anti Hipertensi
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 3/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 4/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 5/161
JNC VII
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 6/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 7/161
AC)*I + ARB
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 8/161
ACE-Inhibitor +
Diuretik
•,arget BP- . /012342 mm5g
. /062372 mm5g i& 89 or
rena di!ea!e :;<
. /0=>3?> i& protein%ria @
0g3=1h
• I& BP @=2302 mm5g above
target BP %!e t$o*dr%g
combination
• 5, ; 89
. BP 062*064372*74-
i&e!tye modi&ication 6mo dr%g
. BP @012342- dr%g
o%rce!- ,he eventh Report o& the Joint Nationa Committee on
Prevention# 8etection# )va%ation# and ,reatment o& 5igh BoodPre!!%re( =226( on!en!%! Pengendaian dan Pencegahan 8iabete! 9eit%!
,ipe = di Indone!ia( =22D(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 9/161
8i%reti"a antihiperten!i
• Bia!a dipa"ai thiazide . 5C, !inge do!e=>*>2 mg3hari !eama =*1 mingg%
:bia do!i! dinai""an !ebe%m 1 mingg%
to"!i"<
• )&e" 5ipo"aemia :terapi !%pemen ;<#
dehidra!i# hiper%ri!emia :go%t<#
hipergi"emia# 8)
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 10/161
CALCIU CHANNEL BLOC!ERS
• CCB men%r%n"an PR + BP
• 9e"ani!me "erEa pada hiperten!i :dan# pada
!ebagian# angina< - hambat in&%"! caci%m
"e daam !e otot poo! arteria• Pening"atan ri!i"o in&ar" mio"ard# rein&ar"!i
+ "ematian# ter%tama oeh !hort acting CCB
:Ni&edipine<
• Piihan A"lodipine
• Ni&edipine ta"i"ardi
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 11/161
β - BLOKER
• Pen%r%nan Cardiac O%tp%t
• 9etoproo + Atenoo- β1-cardioselective
• Beta'oo + bi#oprolol - F 0 *!eective boc"er! yang
metaboi!me primernya di hepar# tapi $aktu paruhn%a
la"a
• Nebivoo -F 0 *!eective boc"er dan va!odiator
• Labetalol - p%nya ra!io 6-0 !ebagai antagoni! F- per
ora tanpa pengar%h 5R dan CO indi"a!i hiperten!i
"arena pheo&hro"o&%to"a + h%perten#i'ee"er(en&ie#
• Car'edilol# antagoni! F dan :~ abetao< indi"a!i
HT + heart )ailure
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 12/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 13/161
Obat 5, dengan Indi"a!i h%!%!
o%rce- ,he eventh Report o& the Joint Nationa Committee on Prevention# 8etection# )va%ation# and,reatment o& 5igh Bood Pre!!%re( =226(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 14/161
8r%g
combination! in
hyperten!ion-
recommendation!
Preferred
ACEInhibitor/diuretic
ARB/diuretic
ACE-Inhibitor/CCB
ARB/CCB
Acceptable
Beta-blocker/diuretic
CCB (dihydropyridine)/beta-blocker
CCB/diuretic
Renin inhibitor/diuretic
Renin inhibitor/CCB
Dihydopyridine CCB/non-dihydropyridine CCB
Unacceptable
ACE-Inhibitor/ARB
Renin inhibitor/ARB
Renin inhibitor/ACE-Inhibitor
RA inhibitor/beta-blocker
CCB (non-dihydropyridine)/beta-blocker
Centrally actin! a!ent/beta-blocker
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 15/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 16/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 17/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 18/161
Anti Angina
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 19/161
Hn!tabe Angina
o%rce- )%ropean 5eart Jo%rna :)%ropean ociety o& Cardioogy<( =22D(
iy ( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 20/161
Coronary 5eart 8i!ea!e
o%rce- Porth! )!!entia! o& Pathophy!ioogy Concept! o& Atered 5eath tate!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 21/161
Ac%te Coronary yndrome!
o%rce!- ,*egment )evation 9yocardia In&arction( 5arri!on! Principe! o& Interna 9edicine( 0? th )d( =227( iy ( Ac%te Coronary yndrome!( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 22/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 23/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 24/161
Loka#i #u"batan Lead Arteri !oroner
In&erior II# III# aVK RCA
Antero!epta V0*V= A8
Anteroapi"a V6*V1 A8 :di!ta<
Anteroatera V>*VD# I# aV CKL
Po!terior V0*V= :ta R $ave# notM $ave<
RCA
o%rce!- iy ( )ectrocardiogram( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 25/161
Nitrate
AN,I ANGINA
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 26/161
AN,I ANGINA
I di" i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 27/161
Indi"a!i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 28/161
• ,erapi !pe!i&i" %nt%" mencegah in&ar" myocard dan
"ematian mengand%ng antiplatelet :a!pirin# A8P
receptor boc"er!< and lipid-lo$erin( a(ent##
"h%!%!nya !tatin
• Hnt%" terapi r%matan chronic !tabe angina# lon(-a&tin(
nitrate## &&b# ata% * blo&ker# bi!a dipiih dr%g o&
choice tergant%ng individ%a re!pon!e(
• Pada 5,# monotherapy dengan !o$reea!e ata% ong*
acting ccb or F boc"er! m%ng"in ade%ate(
• Pada normoten!i# ong*acting nitrate! m%ng"in coco"(
• ombina!i * blo&ker + &&b :eg# propranoo ;
ni&edipine< ata% = CCB berbeda :eg# ni&edipine and
verapami< ebih e&e"ti&
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 29/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 30/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 31/161
Pembl! dara!
) b i P 8V,
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 32/161
)mboi Par% ec 8V,
• ,em%an "a!i" . ,a"i"ardia . ,anda= di!&%ng!i RV
• 8i!ten!i vena E%g%er • Left parasternal lift • = "omponen
p%mona mengera!• 9%rm%r !i!toi" yg
mening"at padain!pira!i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 33/161
Acute Limb Ischemia
• Pen%r%nan per&%!ie"!tremita! !ecaramendada" yang dapatmengancam viabiita! Earingan
• On!et , "in((u• DP Pain# paor#
p%!ee!!ne!!#pare!the!ia# poi"iothermia#parai!i!
• Goden period- D Eam• 8'- arteriogra&i 8opper
"orce# $nter-"ociet% &onsenss 'or t!e (anagement o' PA) * +A"& $$ ,idelines* .
Ch i Li b
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 34/161
Chronic Limb
Ischemia
• In!%&i!ien!i arteriperi&er , "in((u
• !laudika#io
inter"itten . 8ipic% a"tivita! +
eeva!i t%ng"ai . 9etaboi!me
anaerob a!ama"tat muscle
cramping . Nyeri ata%
b%rning padapantar pedi!
• 8'- ABI
"orce# 0asclar )isease o' +!e Etremities* Harrison2s Principle o' $nternal (edicine* 13t! ed* .
Tro"boan(iti# R1 in)la"a#i non-atero"ato#a .'a#o#pa#"e0 pada arteri 2
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 35/161
(obliteran# .Buer(er/#di#ea#e0
. p 0 p'ena ke&il ulku# atau (an(ren di(iti
Laki-laki "uda3 perokok
8iabetic arteriopathy 9a"rova!"%er- CA8# PA8# CVA
9i"rova!"%er- retinopati# ne&ropati# ne%ropati# gangren
Giant ce arteriti! Va!"%iti! pada percabangan "rania ar"%! aorta# ter%tama a(,emporai! :tempora arteriti!Q< ; demam# &atig%e# BB t%r%n#anore"!ia
Arteri*arteri $aEah
"a%di"a!io mandib%a
Chronic imb i!chemia ,er%tama arteri e"!tremita! ba$ah !eteah "e%ar daripercabangan aortoiia"a :a( Iia"a# a( Kemorai!# a( ,ibiai!# a(8or!ai! pedi!<8'- ABI /2(4
Arteriti! ,a"aya!% Va!"%iti! gran%omato!a !i!temi" aorta dan
percabangannya a( %b"avia + a( Brachiocephaica
a%di"a!io e"!tremita!# p%!a!i a( Bra"hiai!# perbedaan,8 @02 mm5g antara "ed%a engan# br%it a( !%b"avia ata%aorta
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 36/161
Penya"it Jant%ng Re%mati"
• e"%eae demamre%mati" a"%t yangtida" di*t' ade"%at
• 9ani&e!ta!i 02*62 th
pa!ca 8RA• Penya"it Eant%ng
"at%p . S- &%!i "omi!%ra
fish mouth . AI ; 9 . AS ; AI ; 9
o%rce- Vav%ar 5eart 8i!ea!e( iy ( Pathophy!ioogy o& 5eart 8i!ea!e( 1th ed( =22?(
abatine 9( Poc"et 9edicine( 1th ed( =200(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 37/161
)ndo"arditi! In&e"ti&
o%rce- e'ton 8J( 8iagno!tic Approach to In&ective )ndocarditi!( Avaiabe at-
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 38/161
Penya"it Eant%ng re%mati" Penya"it Eant%ng "at%p :9# A# AI<# ri$ayatdemam re%mati" a"%t# t' tida" ade"%at
Peri"arditi! Nyeri dada taEam# menEaar "e m( ,rapezi%!# S dgre!pira!i# dg d%d%" "e depan#Pericardia &riction r%b ;3*( )&%!i peri"ardia ;3*
)G- , eeva!i di&%!# o$ MR bia e&%!iperi"ardia
9yo"arditi! T peri"arditi! ; S ,roponin,anda*tanda C5K
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 39/161
Penya"it Jant%ng ongenita
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 40/161
P8A
• P8A "eci- a!imptomati"• P8A be!ar- !imptomati"
IS4B berulan(# takikardia3poor )eedin(3 #lo$ (ro$th . S airan "e par%
. %!ia = . 6 b%an !aat
tahanan va!"%er par%t%r%n
• Pira% dari "iri "e "anan be!ar beban vo%me V + A diata!i A# V e&t heart&ai%re
• Hiperten#i pul"onal tahanan va!"%er par% tinggi
penya"it va!"%er par% reversed shunting #iano#i##iano#i#
.#.#indro"a Ei#en"en(er0
BA5I 4REATUR• otot poo! va!"%er par% be%m
!emp%rna• tahanan va!"%er t%r%n ebih cepat
• gaga Eant%ng ebih a$a
o%rce- Congenita 5eart 8i!ea!e( Pathophy!ioogy o& 5eart 8i!ea!e( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 41/161
Patent 8%ct%! Arterio!%!
PDA kecil murmur kontinyu – machinery murmur
pirau kiri - kanan saat fase sistolik dan diastolik
PDA besar – PH
pulsus celler S2 (P2) keras murmur kontinyu
pirau masih kiri - kanan
fase sistolik dan diastolik murmur sistolik
pirau kiri - kanan hanya
fase sistolik tidak terdengar murmur murmur diastolik awal
aliran melewati katup mitral
%b"avia !ini!tra
o%rce- Roebiono P( Penya"it Jant%ng Ba$aan- ect%re( =224(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 42/161
Ca%dicatio intermitten
• Intermittent ca%dication a"ibat dari ob!tr%"!iairan darah oeh atheroma! pada arteri !edang
dan be!ar
• 4ento1i)%lline # a 'anthine derivative# i! tho%ght
to act by red%cing the vi!co!ity o& bood#ao$ing it to &o$ more ea!iy thro%gh partiay
ob!tr%cted area!(
• Cilo#ta6ol# a pho!phodie!tera!e type 6 :P8)6<
inhibitor# i! poory %nder!tood# b%t may have
!eective antipateet and va!odiating e&&ect!(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 43/161
HeArt 5ailre
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 44/161
Gaga Jant%ng anan
• Cor p%monae- RV enargement ec
primary lung disease RV hypertrophy RV &ai%re• )tioogy-
. P%monary inter!titia di!ea!e- COP8#a!thma# inter!titia %ng di!ea!e
. P%monary va!c%ar di!ea!e- p%monary5,# P)
. 9echanica ventiation- "ipho!coio!i!#obe!ity# OA# ne%rom%!c%ar
• ign! + !ymptom! . H%po1ia tachycardia# cyano!i!# c%bbing . RH7 R7 li)t
. S loud 4,3 ri(ht #ided S8 . R7 )ailure bac"$ard &ai%re
S JVP# hepatomegay :to cardiaccirrho!i!<# a!cite!# peda edema
tric%!pid reg%rgitation RA diation right !ided 1 gaop
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 45/161
Gaga Jant%ng anan
• )CG- RV5:RA8# R@ V0<#
tachyarrythmia
• Ro- RV5 :boot*
!haped# ape"!
terang"at<
De)ibrila#i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 46/161
De)ibrila#i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 47/161
o%rce- Jone! A( )CG Note!- Interpretation and 9anagement G%ide( =22>
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 48/161
8r%g! &or 5eart Kai%re
9olon(an Sub 9olon(an Sediaan
Inotropi" Gi"o!ida Eant%ng Agoni! F*adrenergi"Inhibitor
&o!&odie!tera!e
8igitai!# 8igo"!in# 8igito"!in8ob%tamin Amrinon# 9irinon
8i%reti" oop di%reti",iazid
K%ro!emid5C,B%metanid
9etoazon
Va!odiator AC) inhibitor Rea"!a!i otot poo!ang!%ng
Captopri# )naapri# Ko!inopri# M%inapriNa nitrop%!id# 5idraa!in# I!o!orbid9ino"!idi# Amodipin# Keodipin
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 49/161
Indi"a!i
Gi"o!ida• Conge!tive heart &ai%re
• 8epre!i nod%! AV :pada ta"i"ardi
!%praventri"e paro"!i!ma<
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 50/161
8igo"!inhati*hati pada GAGA GINJA
do!i! dit%r%n"an
8igito"!in
hati*hati pada GANGGHAN KHNGI5)PAR
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 51/161
)RACHNAN 8IGI,AI
G)JAA• )"topi" ventri"e# di!ritmia ventri"e#
ta"i"ardi atria paro"!i!ma dengan
bo"# bo" Eant%ng deraEat = ata% 6:"ompet<
• Anore"!ia# N3V# nyeri abdomen
• Per%bahan per!ep!i "%ning*hiEa%#ha%!ina!i vi!%a# p!i"o!i!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 52/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 53/161
P)NGOBA,AN )RACHNAN 8IGI,AI• top gi"o!ida + di%reti"a yang "e%ar ;
• Ra$at ICH
•)G "ontiny%
• Beri &enitoin# ido"ain# pro"ainamid %nt%"
ta"iaritmia
• Beri ai%m bia AV bo"# "ontraindi"a!i
• Beri Ig antidigo"!in
• 5indari "ardiover!i ee"tri"
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 54/161
Anti Aritmia
Ob t A ti it i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 55/161
Obat Antiarit"ia
9olon(an obat ekani#"e !er:a 2 &ontoh obat
ea! I Obat*obat yang men%r%n"an re!pon membran mea%i bo"ade"ana Na# di"eompo""an !e!%ai e&e"nya pada repoari!a!i- A(%inidin# pro"ainamid# di!opiramidB(ido"ain# &enitoin# to"ainidC()"ainid# &e"ainid
ea! II Obat*obat yang menghambat a"tivita! !impati" mea%i inhibitor Fadrenergi"- A(PropanooB(Obat F bo"er !eEeni!
ea! III Obat*obat yang memperpanEang poten!ia a"!i- A(AmiodaronB(Bretii%m
ea! IV Obat*obat yang menghambat airan ma!%" Ca yang ambat- A(Verapami
B(Obat bo"er "ana Ca
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 56/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 57/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 58/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 59/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 60/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 61/161
A ti it i i di k i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 62/161
Antiarit"ia %an( #erin( dipakai
9olon(an 4reparat
Inhibitor "ana Na %inidin# Pro"ainamid# 8i!opiramid# Aprindinido"ain# 9e"!iatin# Kenitoin# ,o"ainid
Inhibitor "ana Ca AmiodaronVerapami# 8itiazem
impatopegia Propanoo# Bretii%m
Indi"a!i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 63/161
Indi"a!i
%inidin• Aritmia ventri"e + e"topi" ventri"e
• K%tter :Atria Kibria!i< !ebe%mnya
diberi digitai! ata% β blo6er nt6!indari vagoliti6 pada nods A0
7 Kontra6si prematr atrial
Pro"ainamid :T "%inidin<
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 64/161
8i!opiramid• ,a"i"ardi ventri"e
7 Kontra6si e6topi6 ventri6el
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 65/161
ido"ain• 8i!ritmia ventri"e
Kenitoin
• 8i!ritmia ventri"e pada "erac%nan
digitai!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 66/161
Bretei%m• Aritmia ventri"e di ICH
Amiodaron
• 8i!ritmia atria + ventri"%ar yang
re!i!ten terhadap obat
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 67/161
)iabetes
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 68/161
In!%in
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 69/161
In!%in
%mber- on!en!%! Pengendaian dan Pencegahan 8iabete! 9eit%! ,ipe = di Indone!ia( P)R)NI =22D(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 70/161
A8 +
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 71/161
A8 +
55o%rce- Wo!dor& J(# et a(
IPA8 Cinica Practice
Con!en!%! G%ideine! =22D*=22?- 8iabetic "etoacido!i!(
9anaEemen 55
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 72/161
9anaEemen 55
•Rehidra!i agre!i& • 0*6 N 2(4X = Eam
. Ji"a Na;@0>2- ar%tan hipotoni" NaC2(1>X
•Pa!ca hemodinami" !tabi- menggantide&i!it cairan 7*02 daam 0*= hari . NaC 2(1>X a% 8>W
. In&%!ion rate! o& =22.622 m3h o&hypotonic !o%tion
• In!%in :!hort acting< . Bo%! 02 IH ata% 2(0> IH3"gBB
. 8rip 2(0 IH3"gBB3Eam
o%rce!- 8iabete! 9eit%!( 5arri!on! Principe! o& Interna 9edicine( 0? th )d( =227(
Pet%nE%" Pra"ti! ,erapi In!%in pada Pa!ien 8iabete! 9eit%!( P)R)NI =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 73/161
)islipidemia
5ipertrigi!eridemia
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 74/161
5ipertrigi!eridemia
9anaEemen 8i!ipidemia-0( ,ent%"an !a!aran 8
=( 9odi&i"a!i gaya hid%p D mingg%
6( ,erapi &arma"oogi!0( 8
=( ,G
Ei"a @ =22 pa!ca !a!aran 8 tercapai# 8 dosisstatin ata tamba!6an asam ni6otinat:;brat Hiper+, s*d* <=>. mg:dL# statin dptdigna6an
Hiper+, <?.. mg:dL
trn6an +,@
;brat6( 58
I& i!oated o$ 58 in C58 e%ivaent- nicotinicacid# &ibrate
o%rce!- Pet%nE%" Pra"ti! Penataa"!anaan 8i!ipidemia( P)R)NI =221(
Nationa Choe!tero )d%cation Program( Cinician! Poc"et Re&erence( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 75/161
o%rce!- Pet%nE%" Pra"ti! Penataa"!anaan 8i!ipidemia( P)R)NI =221( Nationa Choe!tero )d%cation Program( Cinician! Poc"et Re&erence( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 76/161
5iper*8 ata% 5iper o*, aspan lema6 total lema6
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 77/161
9anagement o& 8y!ipidemia in Ad%t!( Am Fam Physician( 0447
Cen!
5iper*,G a!%pan "arbohidrat# a"oho# ema"
)&e" obat terhadap "adar ipid !er%m
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 78/161
)&e" obat terhadap "adar ipid !er%m
:per"eni<
Obat !ol-LDL !ol-HDL T9
tatin ?@- ↑ >*0>X ↓ ?*62X
Re!in ?->< ↑ 6*>X * 3 ↑
Kibrat ↓ >*=>X ↑ 02*=2X ,<-<
A!am ni"otinat ↓>*=>X ↑ 0>*6>X ,<-<
Penghambatab!orb!i "oe!tero
?-?@ ↑ 6*1X *
Statin# .H9-CoA Redu&ta#e Inhibitor#0
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 79/161
Co""on eature#
• 8ecrea!e 8 + V8• It i! !tandard therapy to initiate
red%cta!e inhibitor therapy immediatey
a&ter myocardia in&arction# irre!pectiveo& ipid eve!
• Hepatotok#ik3 rhabdo"%ol%#i#
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 80/161
Kib t
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 81/161
Kibrate
• H%pertri(l%&eride"ia dimana V8predominan dan
dy!betaipoproteinemia(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 82/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 83/161
+!%roid Endocrinelain
Grave! 8i!ea!e
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 84/161
Grave ! 8i!ea!e
• A%toimm%ne thyroid*!tim%ating Ig :TSI<#antithyrogob%in# ANA
• Ca%!e! D2*72X o&thyroto'ico!i!
• Kemae-mae T >*02-0#12*D2 y
• Cin( 9ani&e!ta!ion- . Di))u#e3 nontender
(oiter Th%roid bruit .+0 . Papitation# !$eating#
an'io%!ne!!# &atig%e#$ea"ne!!# $eight o!!#
diarrhea#oigomenorrhea
. Ophtamoogy . Pretibia my'edema . P%mmer! nai
Ophtamoogy-
preorbita
edema#
conE%nctiva
inEection#
propto!i!
eparated
&ingernai! &rom
naibed
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 85/161
o%rce- ,hyroid Gand 8i!order!( 5arri!on! Principe! o& Interna 9edicine( 0?th )d( =227(
retini!me
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 86/161
retini!me
• 5ipotiroidi!me "ongenita#bayi# ana"• )tioogi- de&i!ien!i iodine#• 9ani&e!ta!i "ini!-
. Gangg%an pert%mb%hant%ang !hort !tat%re#coar!e &acia &eat%re!#short stature
. Gangg%an per"embanganP retarda!i menta t(%( In %tero
. Coar!e &acia &eat%re! . Protr%ding tong%e
o%rce!- Robbin! + Cotran! Pathoogic Ba!i! o& 8i!ea!e( ?th ed( =22>(
Bate! G%ide to Cinica )'amination(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 87/161
8$ar&i!me 8$ar&i!me pit%itari- !hort !tat%re ec de&i!ien!i gro$th hormone8$ar&i!me ec a"ondropa!ia- !hort !tat%re ec gangg%anpemanEangan t%ang pada ca"ram epi&i!i!
Giganti!me 5iper!e"re!i gro$th hormone pada ana" :!ebe%m pen%t%panca"ram epi&i!i!<
A"romegai 5iper!e"re!i gro$th hormone !eteah pen%t%pan ca"ram epi&i!i!9i"ro!e&ai H"%ran "epaa / *= 8
9i'edema 5ipotiroidi!me pada remaEa ata% de$a!a8itandai dengan meambatnya a"tivita! &i!i" dan menta# &atig%e#apati!# intoeran !%h% dingin# over$eight# !e!a" napa!# edema#broadening and coar!ening o& &acia &eat%re!# idah membe!ar#!%ara !era" dan daam :h%!"y voice<
Creatinine ina!e
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 88/161
Creatinine ina!e
• I!oenzim C- . C!-B .:antun(# N /DX< 8 pada AMI9 miokarditis9
peri6arditis dgn mio6arditis9 r!abdomiolisis9 crushinjury
D CK-MM (otot rangka9 F /?-1..G S pada crushinjury # "eEang# hipertermia maigna# inEe"!i I9
. C!-BB .otak# N T 2X< S pada &edera otak :CVA#tra%ma<# hipertermia maigna# in&ar" "oon
o%rce- Gomea G# 5ai!t A( Cinician! Poc"et Re&erence( 00th ed( =22?(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 89/161
Kass Par
a!%! Gaga Pengobatan
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 90/161
a!%! Gaga e goba a
Feni# !a#u# De)ini#i
!a#u# baru Pa!ien yang tida" pernah mendapat terapi ,B ata%pernah mendapat terapi /0 b%an
!a#u# ka"buh Pa!ien yang pernah dinyata"an !emb%h# timb% agi,B a"ti&
!a#u# (a(al .smear positive failure0
• Pa!ien yang !p%t%m B,A tetap po!iti& !eteahmendapat OA,@ > b%an# ata%• Pa!ien yang menghenti"an pengobatannya !eteahmendapat OA, 0*> b%an dan !p%t%m B,A ma!ihpo!iti&
!a#u# kronik Pa!ien yang !p%t%m B,A*nya tetap po!iti& !eteahmendapat pengobatan %ang :retreatment < eng"apyang di!%pervi!i bai"
DR-TB Re!i!ten!i terhadap ri&i!in dan IN5 ;3* OA, ain
%mber- ,%ber"%o!i! Pedoman 8iagno!i! + Penataa"!anaan di Indone!ia( P8PI =22D(
ategori OA,
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 91/161
g
%mber- ,%ber"%o!i! Pedoman 8iagno!i! + Penataa"!anaan di Indone!ia( P8PI =22D(
5epatiti! Imba! Obat pada ,erapi ,B
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 92/161
%mber- ,%ber"%o!i! Pedoman 8iagno!i! + Penataa"!anaan di Indone!ia( P8PI =22D(
pirometri
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 93/161
• PPO- K)V03KVC /?2X
• 8eraEat- K)V0
"orce# ,lobal "trateg% 'or t!e )iagnosis9 (anagement9 and Prevention o' &!ronic Obstrctive Plmonar)isease* ,OL) ..3*
Bron"ie"ta!i!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 94/161
• 8iata!i bron"hi abnorma +permanen pooling materiap%r%en
• In&ama!i + de!tr%"!i !a%rannapa! %"( menengah &ibro!i!#em&i!ema# bron"opne%monia#
ateeta"!i!• )tioogi-
. In&e"!i- P. aeruginosa, H.influenza
. Non*in&e"!i- ga! ammonia# a!pira!ia!am amb%ng
• 9ani&e!ta!i "ini!- bat%" p%r%enber%ang*per!i!ten# hemopti!i!
• PK- rhon"hi# $heezing• 8'- ro# CT .(old #tandard0
"orce# Bronc!iectasis* Harrison2s Principles o' $nternal (edicine* 13! ed* ..4*
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 95/161
,B $ith m%tipe nod%e!
•9igratory bronchopne%monia•9%tipe nod%e! hea $ith @@@ caci&ied gran%oma! :TB
granulomas are usually 1 or 2 in number•5i!topa!momaTtarget calcification!bull"s#eye calcification in center
o& nod%e :Pathognomonic<
III*learningradiolog%*com
A!ido!i! Re!piratori"
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 96/161
p
Di#order 4roble" Etiolo(% 4h%#i&al )indin(#
9etaboicacido!i!
Gain o& 5; oro!! o& 5CO6*
8iarrhea# R,A# A8#actic acido!i!
%!!ma% re!piratory#dry m%co%! membrane#!peci&ic phy!ica &indingto it! ca%!e
9etaboica"ao!i!
Gain o& 5CO6* or o!! o& 5;
o!! o& ga!tric !ecretion:vomiting<# thiazide3oopdi%retic!
,etany# Chvo!te" !ign#!peci&ic phy!ica &indingto it! ca%!e
Re!piratoryacido!i!
5ypoventiation :CO=
retention<
COP8# a!thma# CNdi!ea!e# OA
8y!pnea# an'iety#cyano!i!# !peci&ic
phy!ica &inding to it!ca%!e
Re!piratorya"ao!i!
5iperventiation :CO= o!!<#
high atit%de
5ypo'ia tachypnea
pne%monia# p%m(
)dema# P)# re!trictive%ng di!ea!e
5yperventiation#cardiac rhythmdi!t%rbance
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 97/161
Pen%a6it Hepar
I"ter%! Ob!tr%"ti&
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 98/161
oe!i!titi! A"%t et ca%!a oeithia!i!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 99/161
• )c ob!tr%"!i d%"t%! !i!ti"%!:bia!anya pada 5artmann! po%ch<
• 9ani&e!ta!i "ini!- . Nyeri per%t "%adran "anan ata!#
inten!ita! + d%ra!i @ epi!ode "oi"biier !ebe%mnya
. 8emam# m%a# m%ntah . 9a!!a ; nyeri te"an "%adran "anan
ata! abdomen# ba$ah iga "anan . 8e&an! m%!"%er . $urphy"s sign :) T D>X# P T 7?X<
• 8'- US9 hepatobilier . oeithia!i!- !en!iti& + !pe!i&i"
. oe!i!titi!- penebaan dinding @> mm#cairan peri"oe!i!ti"# 9%rphy!onogra&i"
HG- po!terior aco%!tic !hado$
+ 9%rphy HG
"orce# Biiary !y!tem( abi!ton! te'tboo" o& !%rgery- the bioogica ba!i! o& modern !%rgica practice( 07th ed( =22?(
NEJM ..4J=>4#4.?
)n!e&aopati 5epati"
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 100/161
p p
• egagaan hatimemetaboi!me N56 ;!%b!tan!i ain edema!erebri ; &a!ene%rotran!mitter
• Pemic%- S ammonia :inta"e#!ir"%a!i enterohepati"<
• Clinical dx ∆MS +asterixis
7 +# protein9 la6tlosa9ri'aimin7 Pro;la6sis o# la6tlosa
ri'aimin
"orce# "abatine ("* Poc6et (edicine* ?t! ed* .11*
Pan"reatiti! A"%t ec oeithia!i!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 101/161
• )tioogi- bat% emped%:12X<#a"ohoi!me :62X<
• 9ani&e!ta!i- nyeriepiga!tri%m menEaar "ep%ngg%ng# ter%!*
mener%!# dg bng667 Lab#
D 8 amilase9 lipase . G S94T >1 "en%okon(
pankreatiti# e& (all#tone
. AP# biir%bin tida"!pe!i&i"
"orce# "abatine ("* Poc6et (edicine* ?t! ed* .11*
Abses %epar
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 102/161
p
• 9ani&e!ta!i "ini!
. Amoebia!i! inte!tina ulku#ber(aun( .flask-shaped ulcer) diare berdarah
. Amoebia!i! e"!trainte!tina menemb%! dinding coon !i!temi"
• A"oebi& li'er di#ea#e .ab#e# hepar0
demam menetap# nyeri epiga!tri%m#diare
• 8'- . 8i!enteri amoeba- &e!e! tro)o6oit
%an( "en(andun( RBC di &e!e!#PCR# %Ei antigen &e!e!
. Amoebic iver di!ea!e US9##erolo(i3 "ikro#kopi #ediaana#pira#i
• ,'- . etronida6ole > 1 < "( -?< hari
o%rce!- Robbin! + Cotran! Pathoogic Ba!i! o& 8i!ea!e( ?th ed( =22>(
%!anto# ( Para!itoogy ect%re ga!trointe!tina mod%e( Kac%ty o& 9edicine Hniver!ity o& Indone!ia(
5epatiti! A"%t
5 titi A
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 103/161
5epatiti! A
• Keca*ora• No
chronicity . Ig9-
ac%tein&ection
. IgG- pa!t
in&ection
5epatiti! B
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 104/161
5epatiti! B• Bood# !e'%a#
perinata
• Inc%bation 0*D :=*6< mo
• Ac%te in&ection- . < #ub&lini&al . 62X Ea%ndice . 0X &%minant
hepatiti!
• Chronicity . >X :ad%t*
ac%ired< . 42X :perinatay
ac%ired< . Cirrho!i!- =2*62X
o& chronic hep B
"orce# "abatine ("* Poc6et (edicine* ?t! ed* .1
Acte 0iral Hepatitis* Harrison2s Principle o' $nternal (edicine* 13t! ed* .
eroogi + Viroogi 5BV
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 105/161
4etanda Interpreta#i
5B!Ag In&e"!i a"ti&3!edang berang!%ng( 9%nc% !ebe%m geEaa= m%nc%
5BeAg B%"ti repi"a!i vir%! dan in&e"tivita!
Ig9 anti*5Bc In&e"!i a"%tWindo$ period :5B!Ag :*<# anti*5B! not yet :;<
Anti*5B! Re!o%!i penya"it a"ti& Petanda im%nita! :petanda t%ngga pa!ca im%ni!a!i<
IgG anti*5Bc In&e"!i 5BV ampa% :5B!Ag :*<< ata% "roni! :5B!Ag :;<<
IgG anti*5Be Repi"a!i vir%! //# in&e"tivita! //
5BV 8NA Repi"a!i a"ti& vir%! di hepar
"orce# "abatine ("* Poc6et (edicine* ?t! ed* .1
5epatiti! C
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 106/161
5epatiti! C /.G
trans'sion9>.G $)
Little evidenceo' seal orperinataltransmission
$ncbation 1->M mo
Acte in'ection# 75%
subcinica >G Candice
&!ronicit% >.G &irr!osis# .G
o' c!ronic"orce# "abatine ("* Poc6et (edicine* ?t! ed* .1
Acte 0iral Hepatitis* Harrison2s Principle o' $nternal (edicine* 13t! ed* .
Bari%m )nema . Ca oore"ta
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 107/161
• IB8- S ri!i"o• GeEaa-
. oon di!ta- per%bahan poade&e"a!i# ob!tr%"!i# "oi" abdomen#hematochezia
. oon pro"!ima- anemia de&( Be!i#
nyeri dull # &e!e! cair • ,%mor mar"er- CA 04*4• creening-
. Bari%m enema Se <-< . oono!"opi god !tandard %t"
!creening e 42X
. C, "oonogra&i
• 8'- Biop!i "oono!"opi
Bari%m enema double
contrast& "ar!inoma an%ar
"on!tri"ti&- apple core'
lesion
o%rce!- ieberman 8A( creening &or coorecta cancer( N)J9 =2246D0-00?4(
$$$(earningradioogy(com
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 108/161
Rea"!i 5iper!en!itivita!
T%pe4rotot%pe
I""une e&hani#"# 4atholo(i& Le#ion#
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 109/161
T%pe%p
Di#order I""une e&hani#"# 4atholo(i& Le#ion#
,ipe I Immediate
Anaphya'i!aergie! bronchiaa!thma :atopic&orm!<
Prod%ction o& Ig) antibody immediateNreea!e o& va!oactive amine! and othermediator! &rom ma!t ce! recr%itment o&in&ammatory ce! :ate*pha!e reaction<
Va!c%ar diation#edema# !mooth m%!cecontraction# m%c%!prod%ction# in&ammation
,ipeII
Antibody*mediated
A%toimm%nehemoytic anemiaGoodpa!t%re!yndrome
Prod%ction o& IgG# Ig9 bind! to antigenNon target ce or ti!!%e phagocyto!i! orNy!i! o& target ce by activatedcompement or Kc receptor! recr%itment
o& e%"ocyte!
Ce y!i! in&ammation
,ipeIII
Imm%necompe'mediated
y!temic %p%!erythemato!%!!ome &orm! o&gomer%onephriti!!er%m !ic"ne!! Arth%! reaction
8epo!ition o& antigen*antibody compe'e!compement activation recr%itment o&N N
e%"ocyte! by compement prod%ct! andKc receptor! reea!e o& enzyme! andNother to'ic moec%e!
Necrotizing va!c%iti!:&ibrinoid necro!i!<in&ammation
,ipeIV
Ce*mediated:deayed<
Contact dermatiti!m%tipe !cero!i!type I# diabete!tran!pantreEection
t%berc%o!i!
Activated , ymphocyte! i< reea!e o&Ncyto"ine! and macrophage activation ii<, ce*mediated cytoto'icity
Periva!c%ar ce%arin&itrate! edema cede!tr%ction gran%oma&ormation
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 110/161
8iagno!i! Banding Arthriti!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 111/161
OA RA 9out
Patoogi degenerati& Pann%! 8epo!i!i "ri!ta %rat:mi"rotophi<
On!et grad%a Grad%a A"%t
In&ama!i :*< :;< :;<
o"a!i Pangg%# %t%t#vertebra
9CP# PIP# $ri!t#an"e# "a"i
9,P# "a"i# an"e#
eteribatan !endi Poi Poi# !imetri! 9ono
,em%an "ha! Nod%! Bo%chard#5eberden
8evia!i %nar# !$annec"# bo%tonniere
ri!ta %rat
)"!traarti"%er * Nod% !%b"%tan#p%moner# "ardia"#!penomegai
,ophiBat% ginEaB%r!iti! oe"ranon
ab dbn RK :;<# anti*CCP :;< S a! ( Hrat
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
Go%t
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 112/161
Chronic Go%t
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 113/161
7 (ani'estation# top!i9 nep!rolit!iasis9 brsitis9 c!ronictop!aceos got
&!ronic treatment#7 rate prodction MloI prine diet
7 M- de!%dration drgs Mt!ia"id9 oo# diuretic9#$ra"inamide7 &ro#!$axis 'reent attac6 I!en starting
anti!%perricemic t!erap% M"A$)9 colc!icine
7 Anti!$#eruricemic goal A Q mg:dL
D $'# top!i M9 nep!rolit!iasis M9 or 'reent attac6 Mmin* attac6s9 ric acid </ mg:dL
D ant!ine oidase in!ibitor Mao#urinoD ricosric M#robenecidDo not start w/o prophylaxis & until 2-4 wk after acute attack
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
Go%t and Other Cry!ta Arthropathie!( 5arri!on! Principe! o& Interna 9edicine( 0?th ed( =227(
Rhe%matoid Arthriti!
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 114/161
• ign!- &hroni&##%""etri& pol%arthriti#
• Pathoogy- In&ammatory#proi&erative !ynoviati!!%e :pann%!<
&ormation<# idiopathic#genetic
• 4ain3 #$ellin(3 "ornin(#ti))ne## ? h
• PIP# 9CP# $ri!t!# "nee!#an"e!# 9,P!# cervica!pine
• Joint de&ormitie!
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 115/161
o%rce- Aetaha et a( =202 Rhe%matoid arthriti! ca!!i&ication criteria( Arth (heum( =202
eptember?D-=>D4.70(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 116/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 117/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 118/161
Hematologi
Anemia
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 119/161
Anemia Apa!ti"
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 120/161
• Hipo#elularita# !%m!%m t%ang
• 4an#itopenia . Anemia . e%"openia in&e"!i ber%ang . ,rombo!itopenia petechiae# p%rp%ra
• Bimoda pea" remaEa + an!ia• )tioogi-
. Idiopati" . 8e!tr%"!i !e p%nca- radia#i# ke"o# "imia
:benzen< . R' obat idio!in"rati"- klora")enikol#
NSAID# #ul)a# prep( )ma!# "arbamazepin . 7iru#- 55V*D# 5IV# )BV# parvo*B04#
po#thepatiti# .non A3 B3 C0
• 8'- . Pan!itopenia dg RI /=X . Biop!i !%m!%m t%ang
%m!%m hipoproi&erati&# diganti"an
oeh Earingan ema"
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
Anemia 9egaoba!ti"
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 121/161
ANEIA A!ROSITI!
• nemia megalo!lastik gangg%an !inte!i! 8NA . De)i#ien#i a#a" )olat
• 9an%tri!i :a"ohoi"# vegan<• Ggn metaboi!me &oat :pirimetamin#
trimetoprim<
7 8 demand M!amil9 dialisis . De)i#ien#i B?, neuropati
:peri&er# "o%mna aterai! +po!terior tra"t%! !pinothaami"%!#"orte"! !erebri< baa# pare!te!i#!en!a!i po!i!i + vibra!i# demen!ia#ata"!ia
• 9an%tri!i :a"ohoi"# vegan<• Anemia perni!io!a• Ga!tre"tomi #Crohn!# !pr%e
• nemia non-megalo!lastik - iverdi!ea!e# a"ohoi!me
H"%ran eritro!it @ im&o!it# ova :ma"ro*
ovao!it<
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
9%tipe myeoma
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 122/161
p y
• 9aignan!i !e B Ab mono"ona Ig9• GeEaa-
. Proi&era!i !e pa!ma di !%m!%m t%ang ane"ia . Le#i litik tulan( n%eri tulan(# )raktur ko"pre#i3
hiperCa,+
. In)ek#i berulan( ec hipogammagob%inemia . 9in:al protein light chain to"!i" thd ginEa gaga
ginEa# !indroma ne&roti"
• )e"tro&ore!i! 5b- Ben&e-Fone# protein :ight chain<
• 5ap%! darah tepi- ro%ea%'• Biop!i !%m!%m t%ang- pa!ma!ito!i! @02X
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 123/161
9%tipe p%nch*o%t e!ion! O!teopenia
Kra"t%r "ompre!i
o%rce- $$$(earningradioogy(com
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 124/161
ani)e#ta#i
Kra"t%r"ompre!i
O!teodi!tro&iginEa
Reten!i &o!&at
hiper&o!&atemia
hipo"a!emia hiperP,5
!e"%nder
O!teopenia * o!teoporo!i!
train %mba Nyeri ec regangan padaotot
Nyeri ber%bah dengan pergera"an
O!teomieiti! In&e"!i t%ang ,anda*tanda in&ama!i# demam# e!i iti"t%ang o!teopenia# hiper"a!emia
o%rce!- ,he Pediatric Orthopaedic ociety o& North America(
=20=(
Idiopathic Thrombocytopenic Purpura *ITP
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 125/161
• Tro"bo#itopenia /022#2223mm6• 02X I,P ; anemia hemoiti" a%toim%n +van"s syndrome• )tioogi
. Primer - d' e"!"%!i
. e"%nder- vir%! :5IV# 5CV# 5BV# )BV<# %) Pylori # ANA . Ana"- a"%t pa!ca in&e"!i . 8e$a!a- "roni"
• 9ani&e!ta!i "ini!- perdarahan m%"o"%tan# petechiae#p%rp%ra( Perdarahan !pontan bia ,r /=2#2223mm6
• Pemeri"!aan ab . B,# C, . 5ap%! darah tepi- "e(akario#it . Biop!i !%m!%m t%ang- 8 mega6ariosit
8iate!i! Perdarahan ain
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 126/161
He"ol%ti& Ure"i&S%ndro"e
Thro"boti&Thro"bo&%topeni&
4urpura
8e&ini!i eainan o"%!i& va!"%erec agrega!i pateet
intrarena
eainan o"%!i& va!"%er ecagrega!i pateet !i!temi"
)tioogi higa to'in a"tivita! protea!e **@ vWKdi endote agrega!i
pateet
)pidemioog
i
Ana"# didah%%i diare
berdarah ec )5)C
8e$a!a
9ani&e!ta!iini!
,ria! 5H:trombo!itopenia ;anemia hemoiti"mi"roangiopati" ; gaga
ginEa
Pentad ,,P:trombo!itopenia ; anemiahemoiti" mi"roangiopati" ;Y 9 ; gaga ginEa ;
demam<
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 127/161
4atolo(i ani)e#ta#i
Anemiahemoiti"a%toim%n
A%toim%n:Idiopati"# )# obat :!%&a#ri&i!in# %inidin# NAI8#d<<
Anemia
Anemiaapa!ti" 5ipoproi&era!i !%m!%m t%ang Pan!itopenia
im&oma 9aignan!i!e*!e im&oid di Earingan im&oid
im&adenopati#demam# "eringatmaam
e%"emia 9yeoproi&era!i e%"o!ito!i! ;bi!itopenia
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 128/161
(alaria
9aariaBerat
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 129/161
Berat
o%rce- G%ideine! &or the treatment o& maaria( =nd ed( W5O =20
,ataa"!ana 9aaria Berat
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 130/161
Arte"i#inin I7=I• Arte!%nat IV ata% I9 =(1 mg3"gBB :dibagi = do!i!<
pada 2# 0=# =1 Eam# !eanE%tnya 0(= mg3"gBB d !(d(pa!ien dapat min%m obat :hari 1*><
atau• Artemeter I9 6(= mg3"gBB :dibagi = do!i!<#
!eanE%tnya 0(D mg3"gBB d !(d( Pa!ien dapatmin%m obat ora
ACT lan:utan .4O0
• Artemi!inin ; amodia"%in 6 hari atau• %inin ; tetra!i"in3do"!i!i"in3"indami!in ? hari
o%rce!- G%ideine! &or the treatment o& maaria( =nd ed( W5O =20
9aaria Berat( %doyo AW# d""( B%"% AEar Im% Penya"it 8aam( )di!i IV( =22
Peny%it 9aaria
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 131/161
Bla&k $ater)e'er Ac%te intrava!c%ar hemoy!i! ca!!icay occ%ring a&terthe re*introd%ction o& %inine in ong*term re!ident! inPa!modi%m &acipar%m endemic area! and repeatedy%!ing the prod%ct( 0
CINICA PROKI)- ,he !ymptomatoogy appear!br%tay $ith emi!!ion o& porto*coored %rine# icter%!#
paor# na%!ea# &ever and ac%te rena &ai%re(0
Al(id alaria A rare compication o& tropica maaria and it occ%r! in2(6?X o& ca!e!( Agid maaria i! characterized byhemodynamic di!order! a! !hoc" $ith prono%ncedmetaboic change! and hypothermia(=
A !yndromic diagno!i! o& varying etioogy :dehydration#bacteria in&ection# beeding and3or adrena in!%&&iciency<(6
o%rce- 0< Br%nee K# et a( Bac" $ater &ever( Presse $ed) =22= ep ?60:=7<-06=4*61(
=< Popov AK( Agid maaria( $ed Parasito *$os,( =22> Jan*9ar:0<-02*=(
6< acerda 9V( Agid maaria- a !yndromic diagno!i!( (ev -oc Bras $ed Trop( =224 Jan*
Keb1=:0<-?4*70(
9aaria tertiana :viva'<
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 132/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 133/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 134/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 135/161
PerEaanan Penya"it 9aaria
I#tilah De)ini#i
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 136/161
I#tilah De)ini#i
erangan primer Periode m%ai dari a"hir ma!a in"%ba!i hingga m%ai
terEadi !erangan paro"!i!ma :tria! dingin# menggigi#demam + ber"eringat<
Periode aten Periode a!imptomati" tanpa para!itemia# antara d%a"eadaan paro"!i!ma
Re"%ren!i Ber%angnya para!itemia a!e"!%a !eteah pengobatan(8apat di!ebab"an oeh re"r%den!i# reap! :P( viva' dan P(ovae<# ata% in&e"!i bar%
Re"r%den!i Ber%angnya para!itemia a!e"!%a :dengan in&e"!i yang!ama< pa!ca pengobatan( A"ibat "iren! para!itemia
in"ompit "arena pengobatan yang tida" ade"%at(
Reap!e3rech%te Ber%angnya para!itemia a!e"!%a pada maaria P( viva'dan P( ovae yang dorman :hipnozoit< di hati(8apat terEadi daam interva mingg%*b%an(
o%rce!- G%ideine! &or the treatment o& maaria( =nd ed( W5O =202(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 137/161
+i'oid
8emam ,i&oid
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 138/161
6?2C122C
Co"pli&ation#
Da% -? Da% < Da% Da% ,?
In&ubationperiod
A!ymtomatic
In'a#i'e pha#eIntermitent &ever
5eadache
Kati%e
Abdomina di!com&ort
Con!tipation
8iarrhoea
To1i& pha#eContin%o%! &ever
Bradycardia
5epatomegay
penomegay
Con!tipation
8iarrhoea
Ro!e !pot
Con'ale#&en&eperiod
o%rce!- 5adinegoro R( Kever in Chidren- ect%re( K9HI(=202
Bood c%t%re
Keca c%t%re
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 139/161
• 8' method!- c%t%re o& bood# !too# %rine# d%odena :bie< a!pirate# B9a!pirate !pecimen
• Bood c%t%re- main!tay &or d' e 8 a'ter da%-3• God !tandard- B9 a!pirate• Wida-
. Pening"atan @1' ipat !eteah 0 mingg% menega""an d' . HEi t%ngga dengan titer O 036=2 ata% 5 03D12 ; "ini! menyo"ong d'
o%rce!- Bac"gro%nd doc%ment-,he diagno!i!# treatment and prevention o& typhoid &ever( W5O =226(
Pand%an Peayanan 9edi"( PAP8I =224(
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 140/161
)enge
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 141/161
Amoebic Liver .isease
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 142/161
• 9ani&e!ta!i "ini!
. Amoebia!i! inte!tina
ulku#ber(aun( .flask-shaped ulcer) diare berdarah
. Amoebia!i! e"!trainte!tina menemb%! dinding coon !i!temi"
• A"oebi& li'er di#ea#e .ab#e# hepar0 demam menetap# nyeri epiga!tri%m#diare
• 8'- . 8i!enteri amoeba- &e!e! tro)o6oit
%an( "en(andun( RBC di &e!e!#PCR# %Ei antigen &e!e!
. Amoebic iver di!ea!e HG##erolo(i3 "ikro#kopi #ediaana#pira#i
• ,'- . etronida6ole >1< "( -?< hari
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 143/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 144/161
Helmint!ologi
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 145/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 146/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 147/161
-chistosoma 0aponicum
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 148/161
• ,e%r- lateral kno!:tonEoan di !at% !i!i<
• 8e$a!a- betina!ea% menempe
pada Eantan pada
"anai! gine"opori!
• 5abitat- vena
me!enteri"a ie%!
%!anto# ( Para!itoogy ect%re ga!trointe!tina mod%e( Kac%ty o& 9edicine Hniver!ity o& Indone!ia( =22?
C8C( aboratory identi&ication o& para!ite! o& p%bic heath concern( Avaiabe
-chistosomiasis
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 149/161
• ,ran!mi!i- ho!t !ip%t
!er"aria penetra!i "%itman%!ia
• 9ani&e!ta!i "ini! . A"%t- demam# &%*i"e
!yndrome
. roni"- di!&%ng!i !a%rancerna + hepati"# nyeriabdomen# diare berdarah
• 8'- . 9i"ro!"opi- te%r
. eroogi
• ,'- pra6ikuantel 12*D2mg3"g !at% ata% d%a do!i!
%!anto# ( Para!itoogy ect%re ga!trointe!tina mod%e( Kac%ty o& 9edicine Hniver!ity o& Indone!ia( =22?
C8C( aboratory identi&ication o& para!ite! o& p%bic heath concern( Avaiabe
5IV3AI8
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 150/161
• In&e"!i primer .
Repi"a!i vir%! @@@ ; rapid activation ofC81 e'ha%!tion C81 depetion . A!imptomati"3!imptomati" . A&ute retro'iral #%ndro"e 6*D mg
pa!ca in&e"!i 0*= mg monon%ceo!i!*i"e ine!!
• on!tit%!iona- demam# &%*i"e !y#li")adenopati (enerali#ata• Ne%roogi! :en!e&aiti!# meningiti!#
ne%ropati peri&er<• 8ermatoogi!- rua" "akulolapular
erite"ato#a# ulku# "ukokutan
. Windo$ period - D*0= mingg% !ebe%m Ab :;<• Ka!e aten
. A!imptomati"# &)?• AIDSJ HI7 + CD8 ,<< atau IO
Chronic idney .isease
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 151/161
17( Ac%te idney InE%ry
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 152/161
• G Cr Z>2X &romba!eine# or Sab!o%te by 2(>*0(2mg3d
• Oli(uria . :HO /122 m3=1 h . /2(> m3"g D h<
Anuria :HO /022 m3=1h<
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 153/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 154/161
Nephrotic yndrome
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 155/161
• Protein%ria @6(> g3=1 h• 5ypoab%minemia /6(2 g3
• )dema
• 5yperipidemia
• ipid%ria
• Compication- hypercoag%abe !tate#
in&ection# dr%g to'icitie! ec decrea!edprotein binding
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 156/161
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 157/161
A!ido!i! a"tat
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 158/161
Di#order 4roble" Etiolo(% 4h%#i&al )indin(#
9etaboicacido!i!
Gain o& 5; oro!! o& 5CO6*
8iarrhea# R,A# A8#actic acido!i!
%!!ma% re!piratory#dry m%co%! membrane#!peci&ic phy!ica &indingto it! ca%!e
9etaboica"ao!i!
Gain o& 5CO6* or o!! o& 5;
o!! o& ga!tric !ecretion:vomiting<# thiazide3oopdi%retic!
,etany# Chvo!te" !ign#!peci&ic phy!ica &indingto it! ca%!e
Re!piratoryacido!i!
5ypoventiation:CO= retention<
COP8# a!thma# CNdi!ea!e# OA
8y!pnea# an'iety#cyano!i!# !peci&icphy!ica &inding to it!
ca%!e
Re!piratorya"ao!i!
5iperventiation:CO= o!!<# high
atit%de
5ypo'ia tachypnea
pne%monia# p%m(
)dema# P)# re!trictive%ng di!ea!e
5yperventiation#cardiac rhythmdi!t%rbance
ri!i! ,iroid
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 159/161
o%rce!- ,hyroid Gand 8i!order!( 5arri!on! Principe! o& Interna 9edicine( 0?th )d( =227(
5ipo"aemia
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 160/161
• )tioogy- . ,ran!ce%ar !hi&ting- a"aemia#
in!%in . GI o!!- diarrhea# a'ative
ab%!e
. Rena o!!- 8A# R,A# oopdi%retic!# hyperado!teroni!m
• Cin( 9ani&e!tation- na%!ea#vomiting# ileu## $eakne###"u#&le &ra"p# arr%th"ia#
•)CG- &attening o& , $ave . ,inver!ion# H $ave
o%rce!- abatine 9( Poc"et 9edicine( 1th ed( =200(
H%perkale"ia Keakne##3 )la&&id paral%#i#3 nau#ea3 pare#the#ia3palpitation
7/21/2019 Klu Interna & Farmakologi
http://slidepdf.com/reader/full/klu-interna-farmakologi 161/161
p pEC9J tall T
5yponatremia H!%a%y $ith Na /0=> m)3- na%!ea# vomiting#con&%!ion# ethargy# di!orientationevere :/0=2 m)3< or abr%pt- !eiz%re# coma# death
5ypernatremia Con&%!ion# irritabiity# ethargy# !t%por# coma# m%!cet$itching# !eiz%re
5ypocacemia 5yperactive deep tendon re&e'# carpopeda !pa!m#Chvo!te" !ign# !eiz%re# tetany# aryngo!pa!m)CG- proonged M, interva
5ypercacemia 5,# hypore&e'ia# S ("E&,# s!ortening o' T+ interval
5ypomagne!emia ,achycardia# tremor# m%!ce t$itching# hyperactive re&e'#tetany# !eiz%re